Follow the Pundits

Tag: Institutional Buying

Colorful illustration of a biotech laboratory bench where giant dollar bills swirl around proteomics and genomics machines, while a cartoon Casdin Capital scientist eagerly drops more LAB-branded test tubes into a glowing investment beaker.

Biotech Venture Capital Firm Casdin Keeps Buying Standard BioTools Shares — Time To Invest, Or Time To Label This “Highly Experimental”?

Casdin Capital just scooped up over a million shares of Standard BioTools — again. With strong tech, big cash coming from Illumina, and a major restructuring underway, is this small-cap biotech tools maker a deep-value setup or just another “high-risk, high-lab-cost” gamble? Here’s what’s really going on.

Read entire article

Robinhood logo spotlighted on a theater stage, hedge funds in the audience throwing money, stock chart rising like a curtain. 🎭📈💵

Institutions & Hedge Funds Are Buying and The Stock Is on a Tear. Will Robinhood (HOOD) Keep Stealing the Show?

Robinhood isn’t just stealing trades — it’s stealing headlines. With institutions buying, hedge funds betting, and analysts raising targets, HOOD is on a tear. But can the show go on? 🎟️🔥

 

Read entire article

A robotic arm reaches toward a glowing semiconductor chip with dollar signs floating around it—captioned: 'Cathie Wood Buys More Teradyne (TER)' with Funanc1al’s logo and emoji icons for humor.

Cathie Wood’s Ark Bought More Teradyne (TER)… Should You?

Cathie Wood is doubling down on Teradyne, a robotics and semiconductor test powerhouse with a $1B buyback plan and big AI dreams. Should investors follow? Our fun, fact-filled breakdown has you covered.

Read entire article